Warning: Undefined array key "HTTP_ACCEPT_LANGUAGE" in C:\Apache24\htdocs\search\index.php on line 12

Deprecated: substr(): Passing null to parameter #1 ($string) of type string is deprecated in C:\Apache24\htdocs\search\index.php on line 12
ONO Mayu｜Shinshu University Researcher List

ONO Mayu

Academic Assembly School of Medicine and Health Sciences Institute of Medicine

Shinshu University Hospital　Clinical Division of Breast and Endocrine Surgery　

Assistant Professor　

Researcher Information

Degree

  • Doctor of Medicine, Shinshu University

Field Of Study

  • General surgery and pediatric surgery, Breast and Thyroid Surgery

Mail Address

    bes★shinshu-u.ac.jp
Research activity information

Paper

  • Changes in the pathophysiology of primary hyperparathyroidism and analysis of postoperative recurrence cases at a regional core hospital in Japan: experience of 35 years in Shinshu University Hospital
    Kanai T, Oba T, Morikawa H, Amitani M, Chino T, Shimizu T, Ono MT, Maeno K, Ito KI, Ito T.
    Ann Palliat Med., 2023電子ジャーナル
  • Significance of skeletal muscle index-to-body mass index ratio as a predictor of postsurgical bleeding after mastectomy in patients with breast cancer.
    Morikawa H, Oba T, Kiyosawa N, Iji R, Amitani M, Chino T, Shimizu T, Ono M, Kanai T, Maeno K, Ito KI.
    Breast Cancer., 2023電子ジャーナル
  • Neutrophil-to-lymphocyte ratio is associated with the proportion of poorly differentiated components in papillary thyroid carcinoma.
    Oba T, Kazuma M, Kiyosawa N, Morikawa H, Amitani M, Chino T Shimizu T, Ono M, Ito T, Kanai T, Ito KI.
    J Surg Res, 2023電子ジャーナル
  • Surgical resection of the primary tumor prevents an undesirable locoregional condition and improves the quality of life in patients with anaplastic thyroid cancer.
    Kanai T, Ito T, Morikawa H, Amitani M, Shimizu T, Ohno K, Ono M, Oba T, Maeno K, Ito KI
    Surg Today, 2022電子ジャーナル
  • Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer.
    Amitani M, Oba T, Kiyosawa N, Morikawa H, Chino T, Soma A, Shimizu T, Ohno K, Ono M, Ito T, Kanai T, Maeno K, Ito KI.
    BMC CANCER, 2022電子ジャーナル
  • Prognostic nutritional index is superior to neutrophil-to-lymphocyte ratio as a prognostic marker in metastatic breast cancer patients treated with eribulin.
    Oba T, Maeno K, Ono M, Ito T, Kanai T, Ito KI
    Anticancer Res., 2021電子ジャーナル
  • Prognostic significance of neutrophil-to-lymphocyte ratio for long-term outcomes in patients with poorly differentiated thyroid cancer.
    Oba T, Maeno K, Amitani M, Shimizu T, Ohno K, Ono M, Ito T, Kanai T, Uehara T, Ito KI
    Endocrine J., 2021電子ジャーナル
  • Concomitant use of 18F-FDG PET-CT SUVmax is useful in the assessment of Ki67 labeling index in core-needle biopsy specimens of breast cancer.
    Nakajima H, Maeno K, Ito T, Kanai T, Oba T, Ono M, Takayama F, Uehara T, Ito KI
    Gland Surg., 2021電子ジャーナル
  • HDAC6 inhibition enhances the anti-tumor effect of eribulin through tubulin acetylation in triple-negative breast cancer cells.
    Oba T, Ono M, Matoba H, Uehara T, Hasegawa Y, Ito KI
    Breast Cancer Res Treat., 2021電子ジャーナル
  • The mechanisms involved in the resistance of estrogen receptor-positive breast cancer cells to palbociclib and change over time.
    Ono M, Oba T, Shibata T, Ito KI
    J Cancer Res Clin Oncol., 2021電子ジャーナル